BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 33992053)

  • 1. Recent Advances in Fe-MOF Compositions for Biomedical Applications.
    Zhong Y; Liu W; Rao C; Li B; Wang X; Liu D; Pan Y; Liu J
    Curr Med Chem; 2021; 28(30):6179-6198. PubMed ID: 33992053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in Metal-Organic Frameworks as Anticancer Drug Delivery Systems: A Review.
    Karami A; Mohamed O; Ahmed A; Husseini GA; Sabouni R
    Anticancer Agents Med Chem; 2021; 21(18):2487-2504. PubMed ID: 33463479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metal-Organic Frameworks for Biomedical Applications.
    Yang J; Yang YW
    Small; 2020 Mar; 16(10):e1906846. PubMed ID: 32026590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status and prospects of MIL-based MOF materials for biomedicine applications.
    Lin Z; Liao D; Jiang C; Nezamzadeh-Ejhieh A; Zheng M; Yuan H; Liu J; Song H; Lu C
    RSC Med Chem; 2023 Oct; 14(10):1914-1933. PubMed ID: 37859709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metal Organic Framework (MOF) Particles as Potential Bacteria-Mimicking Delivery Systems for Infectious Diseases: Characterization and Cellular Internalization in Alveolar Macrophages.
    Guo A; Durymanov M; Permyakova A; Sene S; Serre C; Reineke J
    Pharm Res; 2019 Feb; 36(4):53. PubMed ID: 30790066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Biocompatible Iron-Carboxylate Metal Organic Frameworks for pH-Responsive Drug Delivery Application.
    Gupta V; Tyagi S; Paul AK
    J Nanosci Nanotechnol; 2019 Feb; 19(2):646-654. PubMed ID: 30360136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metal organic frameworks as a drug delivery system for flurbiprofen.
    Al Haydar M; Abid HR; Sunderland B; Wang S
    Drug Des Devel Ther; 2017; 11():2685-2695. PubMed ID: 28979098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoscale Iron-Based Metal-Organic Frameworks: Incorporation of Functionalized Drugs and Degradation in Biological Media.
    Christodoulou I; Lyu P; Soares CV; Patriarche G; Serre C; Maurin G; Gref R
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MIL-101 (Fe) @Ag Rapid Synergistic Antimicrobial and Biosafety Evaluation of Nanomaterials.
    Li X; Zheng H; Chen J; Xu M; Bai Y; Liu T
    Molecules; 2022 May; 27(11):. PubMed ID: 35684436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of MOFs in pH-dependent drug delivery systems: progress in the last decade.
    De D; Sahoo P
    Dalton Trans; 2022 Jul; 51(26):9950-9965. PubMed ID: 35726742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metal-Organic Framework (MOF)-Based Drug Delivery.
    Cao J; Li X; Tian H
    Curr Med Chem; 2020; 27(35):5949-5969. PubMed ID: 31215374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metal-Organic Framework in Pharmaceutical Drug Delivery.
    Kundu S; Swaroop AK; Selvaraj J
    Curr Top Med Chem; 2023; 23(13):1155-1170. PubMed ID: 36733193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controllable Synthesis of a Smart Multifunctional Nanoscale Metal-Organic Framework for Magnetic Resonance/Optical Imaging and Targeted Drug Delivery.
    Gao X; Zhai M; Guan W; Liu J; Liu Z; Damirin A
    ACS Appl Mater Interfaces; 2017 Feb; 9(4):3455-3462. PubMed ID: 28079361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoscale MOFs in nanomedicine applications: from drug delivery to therapeutic agents.
    Sun Z; Li T; Mei T; Liu Y; Wu K; Le W; Hu Y
    J Mater Chem B; 2023 Apr; 11(15):3273-3294. PubMed ID: 36928915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biocompatible Fe-Based Micropore Metal-Organic Frameworks as Sustained-Release Anticancer Drug Carriers.
    Leng X; Dong X; Wang W; Sai N; Yang C; You L; Huang H; Yin X; Ni J
    Molecules; 2018 Sep; 23(10):. PubMed ID: 30274195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research progress on antibacterial applications of metal-organic frameworks and their biomacromolecule composites.
    Guo L; Kong W; Che Y; Liu C; Zhang S; Liu H; Tang Y; Yang X; Zhang J; Xu C
    Int J Biol Macromol; 2024 Mar; 261(Pt 2):129799. PubMed ID: 38296133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metal-Organic Framework (MOF)-based Nanomaterials for Biomedical Applications.
    Luo Z; Fan S; Gu C; Liu W; Chen J; Li B; Liu J
    Curr Med Chem; 2019; 26(18):3341-3369. PubMed ID: 29446726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outstanding Drug-Loading/Release Capacity of Hollow Fe-Metal-Organic Framework-Based Microcapsules: A Potential Multifunctional Drug-Delivery Platform.
    Cui R; Zhao P; Yan Y; Bao G; Damirin A; Liu Z
    Inorg Chem; 2021 Feb; 60(3):1664-1671. PubMed ID: 33434431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoporous metal organic frameworks as hybrid polymer-metal composites for drug delivery and biomedical applications.
    Beg S; Rahman M; Jain A; Saini S; Midoux P; Pichon C; Ahmad FJ; Akhter S
    Drug Discov Today; 2017 Apr; 22(4):625-637. PubMed ID: 27742533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metal-Organic Framework (MOF)-A Universal Material for Biomedicine.
    Vodyashkin AA; Sergorodceva AV; Kezimana P; Stanishevskiy YM
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.